Press release
Genotyping Assay Market Report 2024: Global Size, Share, Growth, Trends, Forecast, Competitive Analysis to 2033
The Business Research Company recently released a comprehensive report on the Global genotyping assay Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.According to The Business Research Company's, The genotyping assay market size has grown exponentially in recent years. It will grow from $27.7 billion in 2023 to $33.98 billion in 2024 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to traditional glassware usage, cultural and lifestyle influences, economic factors, hospitality and foodservice industry growth, gift and decor trends.
The genotyping assay market size is expected to see exponential growth in the next few years. It will grow to $77.77 billion in 2028 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to customization and personalization, health and wellness trends, e-commerce growth, smart and functional glassware, culinary and mixology trends. Major trends in the forecast period include material innovation, innovative shapes and designs, smart glassware, specialized glassware for beverages, health and safety features.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report
Market Drivers and Trends:
The increasing prevalence of genetic disorders is expected to propel the growth of the genotyping assay market going forward. Genetic disorders are a group of medical conditions that are caused by abnormalities or mutations in an individual's deoxyribonucleic acid (DNA). Genotyping assays compare the DNA of affected people to that of healthy people to spot changes and can reveal specific genetic mutations or variations linked to a particular genetic disorder. For instance, in June 2023, Gene People, a UK-based registered charity organization supporting individuals with genetic conditions, reported that one in every 25 children in the UK had a genetic disorder, affecting approximately 30,000 newborns and young children in the country as well as more than 2.4 million children and adults annually. Therefore, the increasing prevalence of genetic disorders is driving the growth of the genotyping assay market.
Major companies operating in the genotyping assay market are developing advancements in genomic research such as CE-IVD marked assay to detect treatment-resistant strains of HIV-1. CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit refers to a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics. For instance, in January 2023, Thermo Fisher Scientific, a US-based company launched CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit. This system detects treatment-resistant strains of HIV-1 and has unique features that include assessing genomic mutations, using HIV RNA, detecting drug resistance mutations, using gold-standard Sanger sequencing technology, and is designed for clinical use. The launch of the Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit has added value by improving the detection of treatment-resistant HIV-1 strains, providing ready-to-use reagents and controls, meeting regulatory requirements, having high-performance characteristics, and being compatible with existing sequencing platforms and workflows.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13444&type=smp
Major Key Players of the Market:
F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies plc, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics
genotyping assay Market 2024 Key Insights:
• The genotyping assay market is expected to grow to$77.77 billion in 2028 at a compound annual growth rate (CAGR) of 23.0%.
• Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market
• CE-IVD Marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit For Treatment-Resistant Strains Of HIV-1
• North America was the largest region in the genotyping assay market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13444&type=smp
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genotyping Assay Market Report 2024: Global Size, Share, Growth, Trends, Forecast, Competitive Analysis to 2033 here
News-ID: 3668699 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Genotyping
The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Cri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Genotyping Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Having observed substantial recent expansion, the market dedicated to genotyping is projected to ascend from a valuation of $23.04 billion in the year 2024 to $26.55 billion by 2025, reflecting a compound annual growth rate (CAGR)…
Genotyping Market Future Prediction Report By 2031
Genotyping Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Request Sample…
Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Genotyping Assay Market Size Growth Forecast: What to Expect by 2025?
In recent times, the genotyping assay market has witnessed significant expansion. The market value is projected to rise from $33.98 billion in 2024 to $41.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.4%. Factors…
The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Genotyping Market Size By 2025?
The market size for genotyping has seen a swift expansion in the recent past. Its growth will continue to accelerate from $23.04 billion in 2024, reaching $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The…
Top Factor Driving Genotyping Market Growth in 2025: The Surge In Cancer And Gen …
How Are the key drivers contributing to the expansion of the genotyping market?
The escalating occurrence of cancer and genetic abnormalities is anticipated to drive the genotyping market's expansion. A myriad of diseases falling under the broad term 'cancer' can originate from virtually any tissue or organ in the body. Genetic disorders, meanwhile, are conditions that are completely or largely caused by deviations in the normal DNA sequence. Genotyping enables researchers…
Single Nucleotide Polymorphisms Genotyping Market - Unraveling Genetic Codes, Un …
Newark, New Castle, USA - new report, titled Single Nucleotide Polymorphisms Genotyping Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Single Nucleotide Polymorphisms Genotyping market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Single Nucleotide Polymorphisms Genotyping market. The report offers…
